Skip to main content
Loading market data...
ETF Nasdaq USD

Roundhill GLP-1 & Weight Loss ETF OZEM

Issuer: Roundhill SEC registrant: Roundhill ETF Trust Equity · Global
Watch OZEM (sign in) Add to portfolio (OZEM) Set an alert for OZEM Compare OZEM with other ETFs Position size calculator for OZEM at 30.1 USD

How position sizing works
Last price 30.10 USD Change: Up +1.02 Percent change: Up +3.51%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.59%
Prospectus 1 May 2026
Net assets
$54.1M
As of 30 Jun 2026
Holdings
26
As of 30 Jun 2026
12-month distribution yield
1.36%
Yearly
Asset class
Equity
From holdings

Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund listed on the Nasdaq in the United States, issued by Roundhill. Its category is Equity · Global (equity). Its last price was US$30.10 on 20 Oct 2026. Its expense ratio is 0.59% a year, from its prospectus dated 1 May 2026. It reported net assets of US$54.08 million as of 30 Jun 2026. Its latest holdings report lists 26 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.41 a unit, a 12-month distribution yield of 1.36%, paid yearly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.59%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.59%
Prospectus date
1 May 2026
Filed with the SEC
30 Apr 2026

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$54,078,828
Total assets
$61,010,412
Holdings as of
30 Jun 2026
Report made public
26 Aug 2026 (57 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 26 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

OZEM top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Novo Nordisk A/S US6701002056 12.96% $7.0M Equity (common) Denmark USD
2 Eli Lilly & Co US5324571083 12.69% $6.9M Equity (common) United States USD
3 Mount Vernon Liquid Assets Portfolio, LLC No identifier reported 9.93% $5.4M Short-term investment vehicles (cash funds) United States USD
4 Pfizer Inc US7170811035 6.38% $3.5M Equity (common) United States USD
5 Kailera Therapeutics Inc US4829311020 6.21% $3.4M Equity (common) United States USD
6 Viking Therapeutics Inc US92686J1060 5.86% $3.2M Equity (common) United States USD
7 CSPC Pharmaceutical Group Ltd HK1093012172 5.32% $2.9M Equity (common) China HKD
8 Chugai Pharmaceutical Co Ltd JP3519400000 4.51% $2.4M Equity (common) Japan JPY
9 Ascletis Pharma Inc KYG0520K1094 4.20% $2.3M Equity (common) China HKD
10 Zealand Pharma A/S DK0060257814 3.92% $2.1M Equity (common) Denmark DKK
11 Amgen Inc US0311621009 3.85% $2.1M Equity (common) United States USD
12 AstraZeneca PLC GB0009895292 3.83% $2.1M Equity (common) United Kingdom USD
13 Hanmi Pharm Co Ltd KR7128940004 3.50% $1.9M Equity (common) South Korea KRW
14 Structure Therapeutics Inc US86366E1064 3.05% $1.7M Equity (common) United States USD
15 Roche Holding AG CH1499059983 3.03% $1.6M Equity (common) Switzerland CHF
16 MBX Biosciences Inc US55287L1017 2.80% $1.5M Equity (common) United States USD
17 UNITED LAB United Laboratories International Holdings Ltd/The KYG8813K1085 2.63% $1.4M Equity (common) Hong Kong HKD
18 Jiangsu Hengrui Pharmaceutical Jiangsu Hengrui Pharmaceuticals Co Ltd CNE100006XS6 2.58% $1.4M Equity (common) China HKD
19 Hansoh Pharmaceutical Group Co Hansoh Pharmaceutical Group Co Ltd KYG549581067 2.54% $1.4M Equity (common) China HKD
20 Innovent Biologics Inc KYG4818G1010 2.36% $1.3M Equity (common) China HKD
21 Gubra A/S DK0062266474 1.87% $1.0M Equity (common) Denmark DKK
22 Gilead Sciences Inc US3755581036 1.73% $938K Equity (common) United States USD
23 Rhythm Pharmaceuticals Inc US76243J1051 1.64% $884K Equity (common) United States USD
24 Shionogi & Co Ltd JP3347200002 1.24% $671K Equity (common) Japan JPY
25 WaVe Life Sciences Ltd SG9999014716 0.86% $467K Equity (common) Singapore USD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 30 Jun 2026

All 26 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.59%
Short-term investment vehicles (cash funds) 10.55%

Country

Country by weight
CountryWeightBar
United States 54.77%
Denmark 18.76%
China 17.00%
Japan 5.75%
United Kingdom 3.83%
South Korea 3.50%
Switzerland 3.03%
Hong Kong 2.63%
Singapore 0.86%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 72.43%
Hong Kong dollar (HKD) 19.63%
Danish krone (DKK) 5.80%
Japanese yen (JPY) 5.75%
South Korean won (KRW) 3.50%
Swiss franc (CHF) 3.03%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 45.12%

Partial coverage: sectors are known for 45.1% of net assets (45% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.4100
1 payment per unit
12-month yield
1.36%
Distributions only, not total return
Frequency
Yearly
From the gaps between ex-dates
Latest ex-date
30 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.4100) ÷ latest price ($30.10) × 100 = 1.36%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (2 payments)
OZEM distributions per unit by ex-date
Ex-dateAmount per unit
30 Dec 2025$0.4100
30 Dec 2024$0.0530

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme